| Literature DB >> 34379696 |
Janko Janković1, Stefan Mandić-Rajčević1, Maša Davidović1,2, Slavenka Janković3.
Abstract
BACKGROUND: In 2010, the American Heart Association introduced a new concept of ideal cardiovascular health (CVH) defined as the simultaneous presence of 7 favorable CVH metrics (smoking, diet, physical activity, body mass index, blood pressure, total cholesterol, and fasting blood glucose). The objective of this study was to conduct a systematic literature review and meta-analysis of studies examining the prevalence of ideal CVH, and each of the ideal CVH metrics as well as the relationship between socio-demographic determinants and ideal CVH.Entities:
Mesh:
Year: 2021 PMID: 34379696 PMCID: PMC8357101 DOI: 10.1371/journal.pone.0255959
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Study flow diagram.
A PRISMA flow diagram that details the inclusion and exclusion of studies considered for this systematic review. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Characteristics of included studies.
| First author, year | Country | Study design | Study date | No of population (% male) | Age range; mean age (SD) | Main outcome measures |
|---|---|---|---|---|---|---|
| Bambs CE et al. 2011 [ | USA | Cross-sectional study | Heart SCORE study 2003 | 1933 (34%) | 45–75; 59 (7.5) | Prevalence of ideal CVH, CVH metrics, ideal health behaviors, and health factors |
| Benziger CP et al. 2018 [ | Peru | Cross-sectional study | CHRONICAS 2010 | 3058 (48.7%) | ≥35; 55.6 (12.7) | Prevalence of ideal CVH and CVH metrics, PRs of ideal CVH for education and Wealth index |
| Bi Y et al. 2015 [ | China | Cross-sectional study | 2010 | 96121 (45.7%) | ≥20 | Prevalence of ideal CVH and CVH metrics, ideal health behaviors, and health factors |
| Bundy JD et al. 2020 [ | USA | Cross-sectional nested in cohort study | 1985–2016 | 30447 (39.4%) | 55.0 (13.9) | Prevalence of ideal CVH and CVH metrics |
| Chang Y et al. 2016 [ | China | Cross-sectional study | 2012–2013 | 11113 (46.2%) | ≥35; 53.8 (10.6) | Prevalence of ideal CVH, CVH metrics, ideal health behaviors, and health factors, ORs of ideal CVH for education and family income |
| Chung JWY et al. 2018 [ | Hong Kong, China | Cross-sectional study | 2014–2016 | 626 (9.2%) | >20 | Prevalence of ideal CVH and CVH metrics |
| De Moraes ACF et al. 2019 [ | USA | Cross-sectional study | 2000–2002 | 6792 (47.2%) | 45–84; 62.2 | Prevalence of ideal CVH and CVH metrics |
| Del Brutto OH et al. 2013 [ | Ecuador | Cross-sectional study | Atahualpa 2012; | 616 (40.6%) | 40–99; 59.0 (13.0) | Prevalence of ideal CVH and CVH metrics |
| USA | NOMAS 1993–2001 | 1617 (36.7%) | 40–107; 66.0 (9.0) | |||
| Djousse L et al. 2015 [ | USA | Cross-sectional nested in cohort study | JHS 2000–2004 (baseline visit) | 5301 (36.5%) | 55.3 (12.7) | Prevalence of ideal CVH metrics, ideal health behaviors, and health factors, and number of ideal CVH metrics |
| Fan C et al. 2020 [ | USA | Cross-sectional nested in cohort study | APAC 2012 | 3475 (56.5%) | 45–75 | Prevalence of ideal CVH and CVH metrics |
| Fang J et al. 2019 [ | USA | Cross-sectional study | NHANES 2011–2016 | 6764 (46.5%) | ≥20 | Prevalence of ideal CVH and CVH metrics |
| 5278 NHW (49.4) | 49.9 (0.5) | |||||
| 1486 NHAA (47.6) | 44.5 (0.8) | |||||
| Folsom AR et al. 2011 [ | USA | Cross-sectional nested in cohort study | ARIC 1987–1989 (baseline visit) | 12744 (43.9%) | 45–64; 54.0 | Prevalence of ideal CVH and CVH metrics |
| Foraker RE et al. 2019 [ | USA | Cross-sectional nested in cohort study | JHS 2000–2004 (baseline examination) | 3667 (35.6%) | 35–84; 55.1 | Prevalence of ideal CVH metrics; EEs of ideal CVH score for income and education |
| Gao B et al, 2020 [ | China | Cross-sectional nested in cohort study | National survey 2007–2010 | 45984 (50.4%) | ≥18; 49.2 (15.1) | Prevalence of 5 ideal CVH metrics |
| Gaye B et al. 2020 [ | France | Cross-sectional study | 2007–2011 | 68318 (57.7%) | 43.3 (13.6) | Prevalence of 6 ideal CVH metrics |
| Ghimire U et al. 2020 [ | Nepal | Cross-sectional study | 2013 | 3238 (31.5%) | 15–69 | Prevalence of ideal CVH and CVH metrics, ideal CVH factors and health behaviors, number of ideal CVH metrics, OR of ideal CVH for education |
| Gonzalez HM et al. 2016 [ | USA | Cross-sectional nested in cohort study | HCHS/SOL 2008–2011 (baseline) | 15825 (47.8%) | 18–74 | Prevalence of ideal CVH, CVH metrics and number of ideal CVH metrics |
| Gonzalez-Rivas JP et al. 2019 [ | Venezuela | Cross-sectional study | 2014–2017 | 2992 (47%) | ≥20; 41.4 (15.8) | Prevalence of ideal CVH metrics and number of ideal CVH metrics |
| Graciani A et al. 2013 [ | Spain | Cross-sectional study | ENRICA 2008–2010 | 11408 (49%) | ≥18 | Prevalence of ideal CVH metrics, ideal health factors and behaviours, number of ideal CVH metrics, OR of ideal CVH for education |
| Gupta B et al. 2017 [ | India | Cross-sectional study | 2006–2010 | 6198 (55.3%) | 20–75 | Prevalence of ideal CVH and CVH metrics |
| Harrison S et al. 2019 [ | Canada | Cross-sectional study | 2015–2017 | 777 (49.8%) | 18–65; 41.9 (0.1) | Prevalence of ideal CVH and ideal LS7 metrics and distribution of the LS7 score (0–7) |
| Isiozor NM et al. 2020 [ | Finland | Cross-sectional nested in cohort study | KIHD 1984 (baseline) | 2577 (100%) | 42–60; 53.1 (5.1) | Prevalence of ideal CVH, ideal CVH metrics, ideal health behaviors, and health factors |
| Jankovic J et al. 2019 [ | Serbia | Cross-sectional study | NHS 2013 | 11746 (46%) | ≥20; 51.0 (17.4) | Prevalence of ideal CVH metrics, ideal health factors and health behaviors, ORs of ideal CVH for education and Wealth index |
| Jankovic S et al. 2014 [ | Republic of Srpska, BH | Cross-sectional study | 2010 NHS | 4020 (46%) | ≥18; 50.2 (17.6) | Prevalence of ideal CVH and CVH metrics, ideal health factors and health behaviors, OR of ideal CVH for education |
| Kim JI et al. 2013 [ | USA | Cross-sectional study | HONU project 2009 and 2011 | 4754 (41.7%) | ≥18; 52.1 (16.0) | Prevalence of ideal CVH metrics and number of ideal CVH metrics |
| Kim JY et al. 2013 [ | Korea | Cross-sectional nested in cohort study | Seoul Male Cohort Study 1993 | 12538 (100%) | 40–59; 50.0 (5.2) | Prevalence of ideal CVH and CVH metrics |
| Kulshreshtha A et al. 2013 [ | USA | Cross-sectional nested in cohort study | REGARDS study 2003–2007 (baseline) | 22914 (42.0%) | ≥45.0 (65.0) | Prevalence of ideal CVH and CVH metrics |
| Lawrence EM et al. 2018 [ | USA | Cross-sectional study | NHANES 2005–2010 | 689 | 24–34 | Prevalence of ideal CVH and CVH metrics, OR of ideal CVH for education |
| Add Health 2007–2008 | 11200 (51%) | |||||
| Liu Y et al. 2014 [ | China | Cross-sectional nested in cohort study | Kailuan Sudy 2006–2007 (baseline) | 95429 (79.7%) | ≥18–98; 51.5 (12.5) | Prevalence of ideal CVH and CVH metrics |
| Lu Y et al. 2015 [ | China | Cross-sectional study | 2013 | 11996 (64.7%) | ≥19; 46.8 (13.0) | Prevalence of ideal CVH and CVH metrics |
| Machado LBM et al. 2018 [ | Brasil | Cross-sectional study | 2008–2010 | 13356 (45.3%) | 35–74 51.7 (8.9) | Prevalence of ideal CVH and CVH metrics, rPSD of ideal CVH for education and income |
| Matozinhos FP et al. 2017 [ | Brasil | Cross-sectional study | 2012 | 41134 (48.4%) | ≥18; 41 (0.15) | Prevalence of ideal 6 CVH metrics, PR of ideal CVH for education |
| Medina-Inojosa JR et al. 2020 [ | Czech Republic | Cross-sectional nested in cohort study | 2014 | 2074 (47.0%) | 25–64; 47.3 (11.3) | Prevalence of ideal CVH and CVH metrics |
| Moghaddam MM et al. 2014 [ | Iran | Cross-sectional nested in cohort study | TLGS 2009–2011 | 4865 (41.2%) | ≥20; 41.4 (13.6) | Prevalence of ideal CVH and CVH metrics |
| Nowicki GJ et al. 2018 [ | Poland | Cross-sectional study | 2015–2016 | 3901 (41.1%) | 35–64; 52.1 (8.2) | Prevalence of ideal CVH and number of ideal CVH metrics |
| Ogunmoroti O et al. 2017 [ | USA | Cross-sectional study | BHSF 2014 | 9056 (26.0%) | 43.0 (12.0) | Prevalence of ideal CVH, ideal CVH metrics and number of ideal CVH metrics, OR of ideal CVH for education. |
| Ommerborn MJ et al. 2016 [ | USA | Cross-sectional nested in cohort study | JHS 2000–2004 (baseline) | 4702 | 35–84 | Prevalence of ideal CVH and numbers of ideal CVH metrics |
| Patel N et al. 2019 [ | USA | Cross-sectional study | NHANES 2007–2010 | 4369 (48.6%) | ≥20; 45.0 | Prevalence of ideal CVH and number of ideal CVH metrics |
| Peng Y and Wang Z 2018 [ | Australia | Cross-sectional study | AHS 2011–2012 | 7499 (44.4%) | ≥18 | Prevalence of ideal CVH and ideal health factors and health behaviors |
| Pilkerton CS et al. 2015 [ | USA | Cross-sectional nested in cohort study | BRFSS 2011 | 341659 (47.9) | ≥18; 51.1 (0.1) | Prevalence of ideal CVH and CVH metrics |
| Ren J et al. 2016 [ | China | Cross-sectional study | SMASH 2011–2015 | 15350 (50.05%) | 18–69; 41.4 | Prevalence of ideal CVH and CVH metrics, ORs of ideal CVH for income and education |
| Seron P et al. 2018 [ | Latin America | Cross-sectional nested in cohort study | CESCAS I 2011–2012 | 5458 (41,1%) | 35–74; 54.8 (10.8) | Prevalence of ideal CVH and CVH metrics |
| Shay et al. 2012 [ | USA | Cross-sectional study | NHANES 2003–2008 | 14515 (50.7%) | ≥20 | Prevalence of ideal CVH and CVH metrics |
| Simon M et al. 2017 [ | France | Cross-sectional study | Paris Prospective Study 3 2008–2012 | 9012 (61.5%) | 50–75; 59.5 (6.3) | Prevalence of ideal CVH and CVH metrics, OR of ideal CVH for education |
| van Nieuwenhuizen B et al. 2018 [ | Ghana | Cross-sectional study | Multi-centre RODAM study 2012–2015 | 3510 (38.0%) | 18–70; 47.0 (12.0) | Prevalence of ideal CVH and CVH metrics |
| Velasquez-Melendez G et al. 2015 [ | Brasil | Cross-sectional study | NHS 2013 | 34362 (48.7%) | ≥18; 43.8 (0.2) | Prevalence of ideal CVH metrics |
| Wu HY et al. 2013 [ | China | Cross-sectional study | CHED 2010 | 1012418 (45.0%) | 20–65; 42.7 (6.4) | Prevalence of ideal CVH and CVH metrics |
| Wu S et al. 2012 [ | China | Cross-sectional nested in cohort study | Kailuan Study 2006–2007 | 91698 (79.4%) | 18–98; 51.5 (12.4) | Prevalence of ideal CVH and CVH metrics |
| Zeng Q et al. 2013 [ | China | Cross-sectional study | DREHM 2009–2012 | 9962 (55.8%) | 20–83; 47.1 | Prevalence of ideal CVH and CVH metrics |
| Zhao Y et al. 2016 [ | China | Cross-sectional study | 2010 | 2693 (33.4%) | 20–80; 51.4 (11.5) | Prevalence of ideal CVH and CVH metrics, ORs of ideal CVH for education and income |
Add Health = National Longitudinal Study of Adolescent to Adult Health; AHS = Australian Health Survey; APAC = Asymptomatic Polyvascular Abnormalities Community study; ARIC = Atherosclerosis Risk in Communities; BHSF = Baptist Health South Florida Employee Study; BRFSS = Behavioral Risk Factor Surveillance System; CHED = Chinese Health Examination Database; CHRONICAS = Center of Excellence in Chronic Diseases; CVH = Cardiovascular health; DREHM = Disease Risk Evaluation and Health Management study; ENRICA = Study on Nutrition and Cardio-vascular Risk; Heart SCORE = Heart Strategies Concentrating on Risk Evaluation study; HCHS/SOL = Hispanic Community Health Study/Study of Latinos; HONU = Heart of New Ulm Screening Participants; JHS = Jackson Heart Study; EE = Effect estimate; KIHD = Kuopio Ischemic Heart Disease study; LS7 = Life’s Simple 7; NHAA = non-Hispanic Asian Americans; NHANES = National Health and Nutrition Examination Survey; NHS = National Health Survey; NHW = non-Hispanic white; NOMAS = Northern Manhattan Study; OR = Odds ratio; PR = Prevalence ratio; REGARDS = The Reasons for Geographic And Racial Differences in Stroke; rPSD = Relative predicted score differences; RODAM = Research on Obesity and Diabetes among African Migrants; SMASH = The Shandong province and the Chinese Ministry of Health collaborative Action on Salt reduction and Hypertension; TLGS = Tehran Lipid and Glucose Study; Wealth index = an aggregation of assets and household facilities.
Argentina, Chile, and Uruguay
Ghanian population in Amsterdam, London and Berlin.
Fig 2Forest plots showing proportions of ideal cardiovascular health metrics and ideal cardiovascular health.
Ideal smoking (A), Ideal diet (B), Ideal physical activity (C), Ideal body mass index (D), Ideal blood pressure (E), Ideal total cholesterol (F), Ideal fasting blood glucose (G), 5, 6 and 7 ideal CVH metrics (H), Ideal CVH (6 and 7 CVH metrics) (I). CVH, Cardiovascular health; CI, confidence interval.
Moderator (subgroup) analyses of ideal cardiovascular health metrics by gender.
| Ideal CVH metric | Gender | No. of studies | Heterogeneity | Meta-analysis | Test of moderators | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Population | P-value | I2 | Model | Proportion | 95% CI | P-value | QM | P-value | |||
| Smoking | F | 33 | 710,944 | <0.001 | 99.99% | Random | 0.814 | 0.746, 0.881 | <0.001 | 22.121 | <0.001 |
| M | 35 | 829,878 | <0.001 | 99.94% | Random | 0.601 | 0.543, 0.658 | <0.001 | |||
| Diet | F | 32 | 684,598 | <0.001 | 99.95% | Random | 0.069 | 0.043, 0.101 | <0.001 | 1.131 | 0.288 |
| M | 34 | 811,803 | <0.001 | 99.94% | Random | 0.050 | 0.031, 0.074 | <0.001 | |||
| Physical activity | F | 32 | 684,598 | <0.001 | 99.98% | Random | 0.382 | 0.294, 0.470 | <0.001 | 1.319 | 0.251 |
| M | 34 | 811,803 | <0.001 | 99.97% | Random | 0.451 | 0.374, 0.528 | <0.001 | |||
| Body mass index | F | 33 | 710,944 | <0.001 | 99.95% | Random | 0.465 | 0.401, 0.530 | <0.001 | 1.129 | 0.288 |
| M | 34 | 827,301 | <0.001 | 99.95% | Random | 0.417 | 0.357, 0.478 | <0.001 | |||
| Blood pressure | F | 33 | 710,944 | <0.001 | 99.93% | Random | 0.420 | 0.365, 0.474 | <0.001 | 8.944 | 0.003 |
| M | 35 | 829,878 | <0.001 | 99.96% | Random | 0.297 | 0.239, 0.356 | <0.001 | |||
| Total cholesterol | F | 32 | 689,719 | <0.001 | 99.96% | Random | 0.569 | 0.502, 0.636 | <0.001 | 0.054 | 0.817 |
| M | 34 | 809,969 | <0.001 | 99.95% | Random | 0.580 | 0.519, 0.640 | <0.001 | |||
| Fasting blood glucose | F | 33 | 710,944 | <0.001 | 99.92% | Random | 0.733 | 0.690, 0.776 | <0.001 | 1.910 | 0.167 |
| M | 35 | 829,878 | <0.001 | 99.96% | Random | 0.684 | 0.629, 0.739 | <0.001 | |||
| 5, 6, and 7 metrics | F | 27 | 648,071 | <0.001 | 99.95% | Random | 0.213 | 0.159, 0.272 | <0.001 | 6.442 | 0.011 |
| M | 29 | 837,000 | <0.001 | 99.93% | Random | 0.127 | 0.092, 0.166 | <0.001 | |||
| Ideal CVH (6 and 7) | F | 21 | 620,728 | <0.001 | 99.95% | Random | 0.055 | 0.032, 0.083 | <0.001 | 4.607 | 0.032 |
| M | 23 | 754,906 | <0.001 | 99.83% | Random | 0.026 | 0.015, 0.039 | <0.001 | |||
CVH = Cardiovascular health; F = Female; M = Male
Test for heterogeneity (Q)
Test of moderators (QM)
Fig 3Forest plots depicting proportions with their confidence intervals of ideal cardiovascular health by age group.
Studies describing the association between socioeconomic variables and prevalence of ideal cardiovascular health.
| First author, year | Outcome | Adjustment for potential confounding | Measure of socioeconomic status (95% CI) |
|---|---|---|---|
| Benziger CP et al. 2018 [ | Ideal CVH metrics (5–7) | Age, sex, site | Education PR |
| Wealth index PR | |||
| Wealth index PR | |||
| Chang Y et al. 2016 [ | Ideal CVH metrics (5–7 vs. 0–4) | Age, sex, marital status | Education OR |
| Family income OR | |||
| Foraker RE et al. 2019 [ | CVH score: sum of 7 ideal CVH metrics ranging from 0 (worst) to 14 (best) points | Age, sex, neighborhood income or education where appropriate | Individual income EE |
| Neighborhood income EE | |||
| Education (bachelor) EE | |||
| Education (graduate) EE | |||
| Ghimire U et al. 2019 [ | Ideal CVH metrics (5–7) | Age, sex, marital status, residence, ethnicity | Education OR |
| Graciani A et al. 2013 [ | Ideal CVH metrics (>6 vs. <1) | Age, sex, self-rated health, and use of health care system | Education OR |
| Jankovic J et al. 2019 [ | Ideal CVH metrics (6–7 vs. 0–5) | Age, sex, type of settlement, marital status | Education OR |
| Wealth index OR | |||
| Wealth index OR | |||
| Jankovic S et al. 2014 [ | Ideal CVH metrics (5–7 vs. 0–4) | Age, sex, type of settlement, marital status, employment | Education OR |
| Lawrence EM et al. 2018 [ | CVH (ideal vs.poor) | Age, sex | Education OR |
| Machado LBM et al. 2018 [ | CVH score: sum of 7 ideal CVH metrics ranging from 0 to 7 | Age, sex, race, educational, family income and study site effect | Education rPSD |
| Age, sex, race, educational level, and study site effect | Family income | ||
| Matozinhos FP et al. 2017 [ | Ideal CVH metrics (5–6) | Education women PR | |
| Education men PR | |||
| Ogunmoroti O et al. 2017 [ | Ideal CVH metrics (6–7) | Age, sex, ethnicity | Education OR |
| Ren J et al. 2016 [ | Ideal CVH metrics (≥5 vs. ≤4) | Age, sex | Personal income + education OR |
| Simon M et al. 2017 [ | CVH (ideal vs. poor) | Education OR | |
| Zhao Y et al. 2016 [ | Ideal CVH (7 ideal CVH metrics) | History of hypertension, diabetes, dyslipidemia, and CVD | Education OR |
| Family income OR |
CI = Confidence intervals; CVH = Cardiovascular health; EE = Effect estimate; PR = Prevalence ratio; rPSD = Relative predicted score differences; OR = Odds ratio; Wealth index = an aggregation of assets and household facilities.
highest compared to lowest
middle compared to lowest
per category increase
lowest compared to highest
women vs. men
highest vs. moderate.